Bristol receives subpoena over Abilify marketing

02/20/2012 | Wall Street Journal, The

The U.S. Attorney's Office for the Southern District of New York subpoenaed Bristol-Myers Squibb in an investigation of the company's marketing practices for antipsychotic Abilify, according to a company filing with the Securities and Exchange Commission.

View Full Article in:

Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ